Navigation Links
Patients Should Be Entitled to "Humane Compensation" if Drug Trials Go Wrong

Professor Desmond Laurence, of the University of London says that most clinical trial patients are under the wrong impression that they compensated for any problem that // arises with the drug. This situation is prevailing because of contracts that are badly worded and do not make anything clear to the patients.

The British Medical Journal reported that accidental and unintentional injuries do sometimes occur during clinical trials and patients are left in the lurch, but the government contends that people are informed about the risks. "If the law were to be observed, patients would be told frankly, in words lay people could readily understand, that they might be seriously injured but with merely discretionary compensation," Professor Laurence wrote in a letter to the BMJ. He said that the wording of most contracts was dubious at most and was not convincing either to an observer of the patients. "The trial sponsor of course may always pay ex-gratia compensation, if it cares to. But if it does not, then the cost of compensation for non-negligent harm falls up on the injured patients themselves," Professor Laurence said. He however admitted that if the volunteers came to know that they were not entitled to any compensation, the number of people showing up at clinical trials will definitely suffer. He cited an example of the wording of a contract to show what he meant, "[The sponsor] will pay compensation for [non-negligent harm]. Any payment would be without legal commitment."
'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
(Date:12/2/2008)...HICAGO, Dec. 2 Breast-Specific Gam...sensitive imaging technique for the diagnosis of,...iagnose breast cancer. BSGI,is a molecular breast...t of,tissue density and discover very early stage...d and magnetic resonance imaging (MRI), BSGI has t...
(Date:12/2/2008)...ut too few patients are having the procedure, stud...ws) -- People with the most common form of epileps... years of life, and dramatically improved quality ...in surgery. , That,s the finding of a new study...nefits of surgery of the temporal lobe region for ...
(Date:12/2/2008)... The latest development in...adiologists and electronic health record systems w... and Annual Meeting of the Radiological Society of... and The Health Story Project (previously known as...ect). , CHICAGO (Busines...
(Date:12/2/2008)..., , WASHINGTON, Dec. 2 /PRNewswire-USNewsw...Dean will deliver the Keynote address at eHealth I... "Taking the Pulse of Health IT: A Critical Review...mmendations for 2009 and Beyond." , , (Logo...CLOGO ) , , The Keynote speech will begin a...
Breaking Medicine News(10 mins):Health News:Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound and MRI for Invasive Lobular Carcinoma 2Health News:Surgery a Boon for Most Common Form of Epilepsy 2Health News:Surgery a Boon for Most Common Form of Epilepsy 3Health News: Health Level Seven and The Health Story Project Announce Publication of Diagnostic Imaging Report Guide at Annual RSNA Meeting : HL7 Clinical Document Architecture (CDA) Implementation Guide Enhances Radiology Reporting 2Health News: Health Level Seven and The Health Story Project Announce Publication of Diagnostic Imaging Report Guide at Annual RSNA Meeting : HL7 Clinical Document Architecture (CDA) Implementation Guide Enhances Radiology Reporting 3Health News: Health Level Seven and The Health Story Project Announce Publication of Diagnostic Imaging Report Guide at Annual RSNA Meeting : HL7 Clinical Document Architecture (CDA) Implementation Guide Enhances Radiology Reporting 4Health News: Health Level Seven and The Health Story Project Announce Publication of Diagnostic Imaging Report Guide at Annual RSNA Meeting : HL7 Clinical Document Architecture (CDA) Implementation Guide Enhances Radiology Reporting 5
...confrontations with husbands may mean bad news for...//increase the risk of death from any cause, espec...Boston University had collected data on the marita...omen to find out how far the stress in marriages c...
...the expression of a gene called BRCC36 in cells of...tion //therapy. The gene BRCA1 is the one that is ...r, and expression of BRCC36 inhibits the former pr...levated levels of BRCC36 when compared to normal b...
...nt study made by researchers of UK, scientists hav...//oxygen level in the blood of the passengers. The...h has become so commonplace today, do have any eff...lying today. The researchers have taken the measur...
...full term pregnancy at the age of 20yrs may be the...hers from Fox Chase Cancer Center in Philadelphia ...ty only after a full term pregnancy. Once the cell... to cancer and earlier the women become pregnant t...
Other Medicine News:
(Date:11/30/2008)...ire-USNewswire/ -- Older adults who exercise regul...ter number of small blood vessels in the brain, ac...meeting of the Radiological Society of North Ameri... University of North Carolina ( UNC) - Chapel Hi...adults who exercise to brain scans of those who do...
(Date:11/27/2008)...e lymphoblastic leukemia relapse cases arise from ... , MEMPHIS, Tenn., Nov. 27 /PRNewswire-USNew...ch Hospital have identified distinctive genetic ch...ymphoblastic leukemia (ALL) that cause relapse. Th... for ALL relapse in children and, ultimately, in a...
(Date:11/25/2008)...ry , , Audio and Web Video Resources to acc... News Blog. Please see the bottom of this release .... 25 A Mayo Clinic stud...they,re having a stroke -- and as a result -- dela... The findings appear in the current issue of Emerg...
(Date:11/25/2008)... Poniard,Pharmaceutical...pany focused on,innovative oncology therapies, an... alternatives for its preclinical research program...urces on the clinical development of picoplatin,...tial commercialization of,picoplatin in the treat...
Breaking Medicine Technology:Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3SXC Health Solutions announces third quarter financial results 28943 1SXC Health Solutions announces third quarter financial results 28943 2SXC Health Solutions announces third quarter financial results 28943 3SXC Health Solutions announces third quarter financial results 28943 4SXC Health Solutions announces third quarter financial results 28943 5SXC Health Solutions announces third quarter financial results 28943 6SXC Health Solutions announces third quarter financial results 28943 7SXC Health Solutions announces third quarter financial results 28943 8SXC Health Solutions announces third quarter financial results 28943 9SXC Health Solutions announces third quarter financial results 28943 10SXC Health Solutions announces third quarter financial results 28943 11SXC Health Solutions announces third quarter financial results 28943 12SXC Health Solutions announces third quarter financial results 28943 13SXC Health Solutions announces third quarter financial results 28943 14SXC Health Solutions announces third quarter financial results 28943 15SXC Health Solutions announces third quarter financial results 28943 16SXC Health Solutions announces third quarter financial results 28943 17SXC Health Solutions announces third quarter financial results 28943 18SXC Health Solutions announces third quarter financial results 28943 19SXC Health Solutions announces third quarter financial results 28943 20PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 1PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 2PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 3PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 4PAREXEL Expands Pioneering Asian Ethnobridging Expertise 8936 5Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 28936 1Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 28936 2Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 28936 3Leading Spanish Health Service Provider Selects Autonomy for Innovation in Healthcare 28936 4LocumTenens com Finds Psychiatrists are Neutral on Universal Healthcare 28934 1LocumTenens com Finds Psychiatrists are Neutral on Universal Healthcare 28934 2LocumTenens com Finds Psychiatrists are Neutral on Universal Healthcare 28934 3
...roof of concept in topical models of,infection , R... Ltd.,(SWX: ARPN) today announced positive results...against a large panel of,clinical isolates, includ...In addition, topical applications of AR-2474 were ...illin resistant,Staphylococcus aureus (MRSA) in pr...
... 2007--The World Health Organization,has released ...in,Pakistan. , So is this another instance where, ...ical industry is denying important vaccines to,poo... London’s Guardian,newspaper, “parents...o allow health workers to administer polio vaccina...
Other Medicine Technology:Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 2Arpida adds novel antibiotic AR-2474 to its preclinical pipeline 3Why Is Polio Spreading in Pakistan? 2
For the quantitative in vitro determination of IgG in serum and plasma. This product is suitable for use on the Aeroset
The URCA (Uric acid) method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of uric acid in serum, plasma and urine.
For the quantitative determination of apolipoprotein B (apo B) in serum and plasma.
The XTRI method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of triglycerides in serum and plasma.
Medicine Products: